Researcher.Life Logo

Clinical Medicine Insights: Oncology : Impact Factor & More

eISSN: 1179-5549pISSN: 1179-5549
JournalOpen Access

Key Metrics

CiteScore
2.5
Impact Factor
< 5
SJR
Q3Oncology
SNIP
0.62
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Clinical Medicine Insights: Oncology

Clinical Medicine Insights: Oncology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SAGE PUBLICATIONS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2000
Publication Time8
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2010
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 8
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Clinical Medicine Insights: Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical Medicine Insights: Oncology

Advances in Immunotherapy for Head and Neck Squamous Cell Carcinoma: Focus on PD-1/PD-L1 Blockade and Beyond
  • 7 May 2026
  • Clinical Medicine Insights. Oncology
Prognostic Impact and Clinicopathological Correlates of HER2 Status in Gastric Cancer: A Multicenter Retrospective Turkish Oncology Group Study
  • 6 May 2026
  • Clinical Medicine Insights. Oncology
Transarterial Chemoembolization Combined With Lenvatinib in the Treatment of Intermediate-Stage Hepatocellular Carcinoma With Hypovascular Nodules: A Retrospective Cohort Study.
  • 1 Apr 2026
  • Clinical Medicine Insights. Oncology
The Patient Experience of Cancer-Related Cachexia: Implications for Patient-Reported Outcomes Measures.
  • 1 Apr 2026
  • Clinical Medicine Insights. Oncology
Cost-Effectiveness of Tarlatamab in the Second-Line Treatment of Refractory Small Cell Lung Cancer From a US Perspective
  • 1 Apr 2026
  • Clinical Medicine Insights: Oncology
Symptom Burden and Healthcare Resource Use in Patients With Claudin 18.2–Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma: A Retrospective Review
  • 29 Mar 2026
  • Clinical Medicine Insights. Oncology
Advances in Immunotherapy for Head and Neck Squamous Cell Carcinoma: Focus on PD-1/PD-L1 Blockade and Beyond
  • 7 May 2026
  • Clinical Medicine Insights. Oncology
Prognostic Impact and Clinicopathological Correlates of HER2 Status in Gastric Cancer: A Multicenter Retrospective Turkish Oncology Group Study
  • 6 May 2026
  • Clinical Medicine Insights. Oncology
Transarterial Chemoembolization Combined With Lenvatinib in the Treatment of Intermediate-Stage Hepatocellular Carcinoma With Hypovascular Nodules: A Retrospective Cohort Study.
  • 1 Apr 2026
  • Clinical Medicine Insights. Oncology
The Patient Experience of Cancer-Related Cachexia: Implications for Patient-Reported Outcomes Measures.
  • 1 Apr 2026
  • Clinical Medicine Insights. Oncology
Cost-Effectiveness of Tarlatamab in the Second-Line Treatment of Refractory Small Cell Lung Cancer From a US Perspective
  • 1 Apr 2026
  • Clinical Medicine Insights: Oncology
Symptom Burden and Healthcare Resource Use in Patients With Claudin 18.2–Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma: A Retrospective Review
  • 29 Mar 2026
  • Clinical Medicine Insights. Oncology

FAQs on Clinical Medicine Insights: Oncology